Cargando…
The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005–2020): A systematic review
BACKGROUND: To depict a comprehensive changing landscape of anti-lymphoma drug clinical trials in mainland China from 2005 to 2020. METHODS: A systematic review was conducted on the China National Medical Products Administration Center for Drug Evaluation platform, the Chinese Clinical Trial Registr...
Autores principales: | Chen, Haizhu, Zhou, Yu, Han, Xiaohong, Shi, Yuankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315394/ https://www.ncbi.nlm.nih.gov/pubmed/34327425 http://dx.doi.org/10.1016/j.lanwpc.2021.100097 |
Ejemplares similares
-
The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
por: Zhong, Qiaofeng, et al.
Publicado: (2021) -
Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011–2020)
por: Chen, Chen, et al.
Publicado: (2021) -
A Descriptive Analysis of Human Rabies in Mainland China, 2005–2020
por: Yue, Yujuan, et al.
Publicado: (2022) -
Pediatric Clinical Trials in Mainland China Over the Past Decade (From 2009 to 2020)
por: Wu, Wen-Wen, et al.
Publicado: (2021) -
Mapping the Distribution of Anthrax in Mainland China, 2005–2013
por: Chen, Wan-Jun, et al.
Publicado: (2016)